6-32974633-C-T

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2

The NM_005104.4(BRD2):​c.201C>T​(p.Ser67=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,614,210 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0054 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00085 ( 7 hom. )

Consequence

BRD2
NM_005104.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.0110
Variant links:
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 6-32974633-C-T is Benign according to our data. Variant chr6-32974633-C-T is described in ClinVar as [Benign]. Clinvar id is 772878.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.011 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0054 (822/152316) while in subpopulation AFR AF= 0.0173 (719/41560). AF 95% confidence interval is 0.0163. There are 4 homozygotes in gnomad4. There are 396 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BRD2NM_005104.4 linkuse as main transcriptc.201C>T p.Ser67= synonymous_variant 3/13 ENST00000374825.9 NP_005095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BRD2ENST00000374825.9 linkuse as main transcriptc.201C>T p.Ser67= synonymous_variant 3/131 NM_005104.4 ENSP00000363958 P2P25440-1

Frequencies

GnomAD3 genomes
AF:
0.00539
AC:
821
AN:
152198
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0173
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.00621
GnomAD3 exomes
AF:
0.00161
AC:
406
AN:
251486
Hom.:
0
AF XY:
0.00142
AC XY:
193
AN XY:
135922
show subpopulations
Gnomad AFR exome
AF:
0.0181
Gnomad AMR exome
AF:
0.00142
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000457
Gnomad OTH exome
AF:
0.000814
GnomAD4 exome
AF:
0.000846
AC:
1237
AN:
1461894
Hom.:
7
Cov.:
33
AF XY:
0.000780
AC XY:
567
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.0207
Gnomad4 AMR exome
AF:
0.00165
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.000116
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000289
Gnomad4 OTH exome
AF:
0.00192
GnomAD4 genome
AF:
0.00540
AC:
822
AN:
152316
Hom.:
4
Cov.:
32
AF XY:
0.00532
AC XY:
396
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.0173
Gnomad4 AMR
AF:
0.00268
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000544
Gnomad4 OTH
AF:
0.00615
Alfa
AF:
0.00341
Hom.:
3
Bravo
AF:
0.00618
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.000711

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

BRD2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 02, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
9.4
DANN
Benign
0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115120098; hg19: chr6-32942410; API